Researcher Spotlight: Damien Redureau
For our Researcher Spotlight features, we interview members of the ADDovenom research team, to find out about their interests, their contributions to the project, and their hopes for the future of venom research Here, we speak with Damien Redureau, a PhD student at the Mass Spectrometry Laboratory (LSM), University of Liège. Can you tell us briefly […]
Researcher Spotlight: Huan Sun
For our Researcher Spotlight features, we interview members of the ADDovenom research team, to find out about their interests, their contributions to the project, and their hopes for the future of venom research. Here, we speak with Huan Sun, a Research Associate in the School of Biochemistry at the University of Bristol. Can you tell […]
Discussing venom with Radio 4’s Rutherford and Fry
Professor Nick Casewell, who leads the ADDovenom team at Liverpool School of Tropical Medicine (LSTM), has taken part in a venom-themed episode of The Curious Cases of Rutherford & Fry. The ‘Venomous Vendetta’ episode of the Radio 4 show was broadcast in November 2021, with Nick contributing alongside Steve Backshall, Dr. Ronald Jenner and Christie […]
First ADDovenom annual meeting kicks off in Bristol
About the meeting (27 – 28th September 2021) : The ADDovenom partners gathered at the Harbour Hotel in Bristol for their first ever face-to-face meeting since the pandemic. Attendees journeyed into Bristol from all over Europe and the UK, including Liverpool, Marseille, and Liège, with our Portuguese partners at iBET joining virtually. The meeting, spread […]
Robert Harrison co-authors Telegraph article on snakebites and Covid
Robert Harrison, Deputy Head of the Centre for Snakebite Research & Intervention at the Liverpool School of Tropical Medicine, has co-authored a comment piece for the Daily Telegraph. ‘How finding an effective treatment for snake bite could help the fight against Covid’ was co-written by Devin Sok, the Executive Director of the IAVI Antibody Discovery […]
Research Associate Positions in Professor Berger-Schaffitzel lab
The role: We are seeking a post-doctoral research associate to perform laboratory-based snakebite envenoming (SBE) research in the Berger-Schaffitzel lab at the University of Bristol. The post-holder will use state-of-the-art protein engineering and display technology to generate high-affinity nanobodies against diverse toxins from snake venoms. These will be selected to neutralise the pathogenic function of […]
Abstract submission: Next-generation sequencing for venomics
ADDovenom researchers Fernanda Gobbi Amorim, Damien Redureau, Nicholas Casewell and Loïc Quinton have co-authored the following abstract, which has been submitted for the Venoms and Toxins 2021: The 8th International Toxinology Meeting (25 – 27 August 2021): Next-generation sequencing for venomics: application of Multi-Enzymatic Limited Digestion for inventorying the snake venom arsenal Multi-Enzymatic Limited Digestion […]
ADDovenom / BBI webinar with Prof Gérard Lambeau
On 5 May 2021, ADDovenom teamed up with colleagues at the Bristol BioDesign Institute to organise a webinar with Professor Gérard Lambeau from CNRS (Centre national de la recherche scientifique). Prof Lambeau’s presentation title was ‘From venom phospholipases A2 to membranous nephropathy, a rare autoimmune kidney disease’. A recording of the webinar is available on […]
27th Meeting of the French Society of Toxinology to be organised by Loïc Quinton
The French Society of Toxinology (SFET) is preparing for its 27th Meeting on Toxinology, entitled “Toxins: Mr Hyde or Dr Jekyll?”, on Thursday 9th and Friday 10th December 2021. This virtual conference will be organised by ADDovenom researcher Loïc Quinton, who sits on the board of Directors. The names of renowned invited speakers will be communicated […]
IMI-EU funding to accelerate Advanced Therapy Medicinal Products
iBET participates in ARDAT – Accelerating Research and Innovation for Advanced Therapies – a project which aims to standardize and accelerate the development of Advanced Therapy Medicinal Products (ATMPs). This project is supported by Europe’s Innovative Medicines Initiative (IMI) with €25.5 million. ATMPs have unprecedented potential to significantly improve patients’ life quality. ATMP research is growing exponentially, […]
